Vectorial transport of the arginine derivatives asymmetric dimethylarginine (ADMA) and L-homoarginine by OATP4C1 and P-glycoprotein studied in double-transfected MDCK cells.


Journal

Amino acids
ISSN: 1438-2199
Titre abrégé: Amino Acids
Pays: Austria
ID NLM: 9200312

Informations de publication

Date de publication:
Jul 2020
Historique:
received: 19 12 2019
accepted: 25 06 2020
pubmed: 10 7 2020
medline: 28 5 2021
entrez: 10 7 2020
Statut: ppublish

Résumé

Elevated plasma concentrations of the uremic toxin asymmetric dimethylarginine (ADMA) and low plasma concentrations of L-homoarginine are independently associated with cardiovascular events and mortality. Key enzymes involved in the homeostasis of both arginine derivatives are expressed in proximal tubule cells of the kidney. To get access to these enzymes, transport proteins are important. One of the transporters mediating the transport of ADMA and L-homoarginine is the solute carrier superfamily (SLC) member OATP4C1, located in the basolateral membrane of proximal tubule cells. To gain insights into the role of export pumps in the transport of both substances, we established a double-transfected MDCK cell line expressing OATP4C1 and the export pump P-glycoprotein (P-gp). Using MDCK cell monolayers, we demonstrated in time-dependent and concentration-dependent vectorial transport experiments that ADMA and L-homoarginine are transported from the basolateral to the apical compartment of MDCK-OATP4C1-P-gp cells with significantly higher transport rates compared to single-transfected MDCK-OATP4C1, MDCK-P-gp and MDCK-VC (control) cells (e.g. transport ratio MDCK-OATP4C1-P-gp/MDCK-VC: for 50 µM ADMA = 2.0-fold, for 50 µM L-homoarginine  = 3.4-fold). These results indicate that both OATP4C1 and P-gp transport the arginine derivatives ADMA and L-homoarginine and are, therefore, important for the homoeostasis of both substances.

Identifiants

pubmed: 32642843
doi: 10.1007/s00726-020-02867-8
pii: 10.1007/s00726-020-02867-8
pmc: PMC7406541
doi:

Substances chimiques

ATP Binding Cassette Transporter, Subfamily B, Member 1 0
Organic Anion Transporters 0
SLCO4C1 protein, human 0
Homoarginine 156-86-5
N,N-dimethylarginine 63CV1GEK3Y
Arginine 94ZLA3W45F

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

975-985

Subventions

Organisme : Deutsche Forschungsgemeinschaft
ID : KO 2120/7-1

Références

Mol Pharm. 2016 Feb 1;13(2):512-9
pubmed: 26702643
Pharm Res. 2002 Jun;19(6):765-72
pubmed: 12134945
J Am Soc Nephrol. 1999 Jun;10(6):1159-69
pubmed: 10361853
Semin Nephrol. 2014 Mar;34(2):191-208
pubmed: 24780473
Pharmacol Rev. 2013 May 17;65(3):944-66
pubmed: 23686349
Mol Pharmacol. 1999 May;55(5):929-37
pubmed: 10220572
J Card Fail. 2014 Dec;20(12):923-30
pubmed: 25230239
Nephrol Dial Transplant. 2002 Nov;17(11):1999-2002
pubmed: 12401860
Semin Dial. 2009 Jul-Aug;22(4):346-50
pubmed: 19708979
J Cardiovasc Pharmacol. 1992;20 Suppl 12:S60-2
pubmed: 1282988
J Am Soc Nephrol. 2006 Aug;17(8):2127-35
pubmed: 16807400
Mol Pharm. 2017 Sep 5;14(9):2991-2998
pubmed: 28708400
PLoS One. 2016 Nov 3;11(11):e0165811
pubmed: 27812151
Circulation. 2010 Sep 7;122(10):967-75
pubmed: 20733103
Methods Mol Biol. 2017;1601:123-135
pubmed: 28470523
Kidney Int. 2003 May;63(5):1934-43
pubmed: 12675874
Amino Acids. 2013 Oct;45(4):989-1002
pubmed: 23864433
Am J Nephrol. 2008;28(2):224-37
pubmed: 17960061
J Am Soc Nephrol. 2002 Mar;13(3):595-603
pubmed: 11856762
J Am Soc Nephrol. 2009 Dec;20(12):2546-55
pubmed: 19875811
Nephrol Dial Transplant. 2014 Mar;29(3):663-71
pubmed: 24398889
Proc Natl Acad Sci U S A. 2004 Mar 9;101(10):3569-74
pubmed: 14993604
Exp Nephrol. 1998 Mar-Apr;6(2):89-97
pubmed: 9567214
Circulation. 2013 Sep 24;128(13):1451-61
pubmed: 24004504
Biopharm Drug Dispos. 2009 Apr;30(3):149-52
pubmed: 19243013
Eur J Clin Invest. 2014 Feb;44(2):200-8
pubmed: 24251815
J Biol Chem. 2000 Mar 17;275(11):7723-30
pubmed: 10713084
BMC Dev Biol. 2005 May 26;5:9
pubmed: 15918910
Circulation. 1999 Feb 2;99(4):552-7
pubmed: 9927403
Annu Rev Pharmacol Toxicol. 2005;45:689-723
pubmed: 15822193
Eur J Pharm Sci. 2004 Jan;21(1):69-75
pubmed: 14706813
Mol Aspects Med. 2013 Apr-Jun;34(2-3):95-107
pubmed: 23506860
Mol Aspects Med. 2013 Apr-Jun;34(2-3):413-35
pubmed: 23506881
PLoS One. 2019 Mar 13;14(3):e0213747
pubmed: 30865704
Pflugers Arch. 2004 Feb;447(5):666-76
pubmed: 12883891
Lancet. 1992 Mar 7;339(8793):572-5
pubmed: 1347093
J Mol Cell Cardiol. 2012 Sep;53(3):392-400
pubmed: 22705145
Sci Rep. 2017 Jul 6;7(1):4767
pubmed: 28684763
Proc Natl Acad Sci U S A. 2005 Dec 13;102(50):17923-8
pubmed: 16330770
Amino Acids. 2015 Sep;47(9):1827-36
pubmed: 26142633

Auteurs

Emir Taghikhani (E)

Institute of Experimental and Clinical Pharmacology and Toxicology, Friedrich-Alexander-Universität Erlangen-Nürnberg, Fahrstrasse 17, 91054, Erlangen, Germany.

Renke Maas (R)

Institute of Experimental and Clinical Pharmacology and Toxicology, Friedrich-Alexander-Universität Erlangen-Nürnberg, Fahrstrasse 17, 91054, Erlangen, Germany.

R Verena Taudte (RV)

Institute of Experimental and Clinical Pharmacology and Toxicology, Friedrich-Alexander-Universität Erlangen-Nürnberg, Fahrstrasse 17, 91054, Erlangen, Germany.

Arne Gessner (A)

Institute of Experimental and Clinical Pharmacology and Toxicology, Friedrich-Alexander-Universität Erlangen-Nürnberg, Fahrstrasse 17, 91054, Erlangen, Germany.

Martin F Fromm (MF)

Institute of Experimental and Clinical Pharmacology and Toxicology, Friedrich-Alexander-Universität Erlangen-Nürnberg, Fahrstrasse 17, 91054, Erlangen, Germany.

Jörg König (J)

Institute of Experimental and Clinical Pharmacology and Toxicology, Friedrich-Alexander-Universität Erlangen-Nürnberg, Fahrstrasse 17, 91054, Erlangen, Germany. joerg.koenig@fau.de.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH